Dry promises: Tap water eludes UP's Bundelkhand despite government claims
Despite rapid infrastructure development, the issue of clean drinking water continues to plague Uttar Pradesh's Bundelkhand. Residents of Chureh Kesharva village in Chitrakoot are facing an acute shortage. Taps, tube wells, and hand pumps dot the villages, but water remains scarce, forcing women and children to travel long distances to fetch it.The seriousness of the situation can be gauged by the fact that a nine-year-old girl, Annu, carries multiple 20-litre buckets of water daily, despite weighing only 15 kg. Her mother attributes their struggle to incomplete tap connections, saying, "The family's plight is due to incomplete tap connections."
advertisementSimilarly, Ranjana, a 12th-grade student in the village, relies on hand pumps for water. She repeatedly fills bucket after bucket, demonstrating her endurance in the face of adversity.
"They promised water connections that never materialised," a resident said, frustrated by the negligence affecting her community.The progress in providing tap water connections under Jal Jeevan Mission in Uttar Pradesh is slow. The Chitrakoot District Magistrate said that efforts are underway to improve supply, promising, "Plans are in place to saturate the area with tap water connections within six months."The Jal Jeevan Mission has approved 40,951 schemes in Uttar Pradesh, with a total budget of Rs 1,52,521.82 crore. Officials have reported 100 per cent tap water coverage in 24,576 villages, benefiting over 4.86 crore people. However, the stark reality in Chitrakoot tells a different story, exposing the gap between policy promises and everyday struggles.Must Watch
IN THIS STORY#Uttar Pradesh
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Standard
an hour ago
- Business Standard
Onesource Specialty edges higher after inking manufacturing pact with biotech firm Xbrane
Onesource Specialty Pharma advanced 1.55% to Rs 2057 after the company announced a partnership with Sweden-based Xbrane Biopharma AB for manufacturing biosimilars for global markets. Xbrane Biopharma AB is a biotechnology company. It develops biological drugs based on a patented platform technology that provides significantly lower production costs compared to competing systems. Xbrane has a portfolio of biosimilar candidates targeting EUR 23 billion in estimated annual peak sales of the respective reference product. The lead candidate Ximluci (a ranibizumab biosimilar) is granted market authorization approval in Europe (launched in 2023) and is now under the approval process for the U.S. launch. As part of the agreement, Xbrane will tech transfer its select product(s) to OneSources integrated drug substance and drug product (DS/DP) facility in Bangalore, India. The collaboration aims to strengthen Xbranes global supply chain, while enabling OneSource to accelerate regulatory approvals, including from the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA), for its biologics drug substance facility. As part of the collaboration, OneSource has also participated in Xbranes latest funding round, reinforcing the long-term alignment between the two companies. Neeraj Sharma, managing director & CEO of OneSource Specialty Pharma, said: The partnership with Xbrane reflects our shared ambition to drive broader access to cutting-edge biologics worldwide. Xbranes proven success in biosimilar development, combined with OneSources fully integrated biologics platform, creates a strong platform for global impact. We are pleased to support the scale-up of high-quality biosimilars and advance our vision of being a trusted partner to the worlds leading biotech companies. OneSource Specialty Pharma is a pure-play specialty pharmaceutical CDMO. The company focuses on the development and manufacturing of complex pharmaceutical products including biologics, drug-device combinations, sterile injectables, and oral technologies (soft gelatine capsules). It has five manufacturing facilities approved by global regulatory authorities and a dedicated team of over 1,200 professionals. On a consolidated basis, OneSource Specialty Pharma reported net profit of Rs 98.50 crore in Q4 March 2025 as against net loss of Rs 40.17 crore in Q4 March 2024. Net sales surged 482.38% YoY to Rs 425.95 crore in Q4 March 2025.
New Indian Express
3 hours ago
- New Indian Express
Rs 20 crore allotted for Bonalu festival; to start on June 26
HYDERABAD: The government has allocated Rs 20 crore for the conduct of the Ashada Bonalu festival, which will kickstart on June 26 and culminate on July 24. Ministers Ponnam Prabhakar and Konda Surekha have instructed officials to organise the festivities in a grand manner. Chairing a review meeting on the festival arrangements, the ministers said the state government would offer silk robes at the Balkampet Sri Yellamma Pochamma temple on July 1. The Hyderabad district in-charge minister said silk robes will be presented to 28 major Mahankali temples. An elephant procession accompanied by Ghatams will commence from Ujjaini Mahankali temple on July 14, followed by Nalla Pochamma Devasthanam Sabji Mandi on July 20 and Akkanna Madanna Devasthanam on July 21.
New Indian Express
3 hours ago
- New Indian Express
Telangana panchayat secretaries threaten mass leave over unmet demands
NALGONDA: Panchayat secretaries across Telangana have announced mass leave from Wednesday following a call by the Joint Action Committee (JAC) to press for the resolution of their long-pending issues. President of the Nalgonda Panchayat Secretaries' Association, SA Qasim, stated that bills worth crores of rupees for gram panchayats have been pending for the past 18 months. He added that during the last two summers, individual secretaries incurred debts ranging from Rs 1 lakh to Rs 10 lakh to ensure an uninterrupted water supply. Qasim also highlighted the tragic death of Indanpally secretary Chandramouli from Jannaram mandal in Mancherial district, attributing it to financial stress caused by unpaid dues.
